Related references
Note: Only part of the references are listed.Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease
Albina Nowak et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Fabry disease in the Spanish population: observational study with detection of 77 patients
Irene Vieitez et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
Maarten Arends et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Newborn screening for Fabry disease in the north-west of Spain
Cristobal Colon et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience
Barbara K. Burton et al.
JOURNAL OF PEDIATRICS (2017)
Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
Giulia Polo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)
Osamu Saito et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2016)
X-chromosome inactivation in female patients with Fabry disease
L. Echevarria et al.
CLINICAL GENETICS (2016)
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
Maria J. Ferraz et al.
FEBS LETTERS (2016)
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L. van der Tol et al.
JOURNAL OF MEDICAL GENETICS (2014)
Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD)
O. Lidove et al.
CLINICAL GENETICS (2012)
Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria
Thomas P. Mechtler et al.
LANCET (2012)
Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
S. M. Rombach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Misdiagnosis in Fabry Disease
Cintia L. Marchesoni et al.
JOURNAL OF PEDIATRICS (2010)
Vasculopathy in patients with Fabry disease: Current controversies and research directions
S. M. Rombach et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Fabry disease
Dominique P. Germain
ORPHANET JOURNAL OF RARE DISEASES (2010)
High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
Hsiang-Yu Lin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2007)
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes.: Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population
R Dobrovolny et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype
S Nakao et al.
KIDNEY INTERNATIONAL (2003)
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3
UH Schueler et al.
NEUROBIOLOGY OF DISEASE (2003)
Fabry disease: enzymatic diagnosis in dried blood spots on filter paper
NA Chamoles et al.
CLINICA CHIMICA ACTA (2001)
Share Paper
